🔎 Trials Near Me

Akèy › Kansè vejik › Kalifòni › San Diego

Etid klinik pou Kansè vejik nan San Diego, CA

11 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote San Diego (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Ap rekriteFaz 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06465069

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Ap rekriteFaz 1/2
  • UC San Diego Medical Center - Bankers Hill, San Diego
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center- Hillcrest, San Diego
  • ak 7 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07421700

DESTINY-PANTUMOUR04

Ap rekriteEtid obsèvasyon
  • Research Site, San Diego
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • University of California, San Diego, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Ap rekriteFaz 2
  • Om research, San Diego
  • University of Southern California, San Diego
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06567743

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Ap rekriteFaz 3
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • Om Research, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • Kaiser Permanente San Diego Mission Road (Regulatory and Lab Supplies), San Diego
  • Kaiser Permanente Zion Medical Center, San Diego
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

Bladder EpiCheck Product Development Study

Ap rekriteEtid obsèvasyon
  • Om Research LLC, San Diego
Laj 22 ak plis · Tout sèks · Mizajou Apr 7, 2026 · NCT07514143

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, La Jolla · 11 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

Ap rekriteFaz 1/2
  • Sharp Memorial Hospital, San Diego
Laj 18 ak plis · Tout sèks · Mizajou Jul 9, 2025 · NCT05086692

Etid Kansè vejik nan lòt vil

Lòt etid nan San Diego

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.